The researchers analyzed 425 patients (mean age, 69 years; 62% men) with cryptogenic stroke, syncope or known AF who were using an implantable loop recorder (Reveal LINQ, Medtronic).

An Ohio State University Wexner Medical Center research team discovered that between 46 percent and 86 percent of health alerts sent by their patients' implantable Medtronic heart monitors were ...

Strategies Deployed in 2020 Jul-2020: Medtronic got FDA clearance for its LINQ II insertable cardiac monitor. This cardiac monitor has been used for the detection and classification of cardiac ...

Three weeks ago, the 67-year-old independent insurance agent had the Medtronic Reveal LINQ Insertable Cardiac Monitor (ICM) System -- also known as a loop recorder -- implanted in the skin above ...

--Medtronic plc, a global leader in healthcare technology, today announced the LINQ II™ Insertable Cardiac Monitor system is the first-and-only ICM to receive 510 clearance by the U.S. Food and ...

Washington Adventist Hospital is part of an international study creating a database of 3,200 patients being monitored with Medtronic’s Linq loop recorder.

Using implantable loop recorders for primary monitoring of patients with unexplained syncope and preserved LV function is more cost effective and diagnostically efficient than conventional testing.

Notably, Medtronic's Cardiac & Vascular Group has been leading innovation in cardiac monitoring for a long time, including Reveal, the world's first loop recorder and Reveal LINQ, the world's ...

Reveal LINQ Loop Recorder Dr. Steven Zweibel was the first physician in Connecticut to implant The Medtronic Reveal LINQ loop recorder.